Endovia Health Sciences, Inc.
EDVA
18 hedge funds and large institutions have $172K invested in Endovia Health Sciences, Inc. in 2026 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
20% more funds holding
Funds holding: 15 → 18 (+3)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
4.33% less ownership
Funds ownership: 6.13% → 1.8% (-4.3%)
29% less capital invested
Capital invested by funds: $244K → $172K (-$71.9K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$90.2K |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$14.7K |
| 3 |
PM
Phraction Management
Colchester,
Connecticut
|
+$13.9K |
| 4 |
Truist Financial
Charlotte,
North Carolina
|
+$9.06K |
| 5 |
SG
StoneX Group
New York
|
+$7.29K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
-$20.1K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$19.1K |
| 3 |
VF
Virtu Financial
New York
|
-$10.4K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$5.96K |
| 5 |
Vanguard Global Advisers
Malvern,
Pennsylvania
|
-$55 |
EDVA Hedge Fund Activity: Q2 2026 in Review
18 of the 8,297 institutional investors tracked by Wall St. Rank reported a position in Endovia Health Sciences, Inc. (EDVA) for Q2 2026, worth a combined $172K — down 29% from $244K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new EDVA positions and 3 closed out — a net gain of 3 holders — while 3 added to existing stakes and 3 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $90.2K. The largest seller was HRT Financial, cutting an estimated $20.1K.
- 18 institutional investors held Endovia Health Sciences, Inc. (EDVA) as of Q2 2026, up from 15 in Q1 2026.
- Funds reported $172K of Endovia Health Sciences, Inc. stock for Q2 2026, down 29% quarter-over-quarter.
- 6 funds opened new Endovia Health Sciences, Inc. positions in Q2 2026 and 3 closed out, a net change of +3 holders.
- The largest Endovia Health Sciences, Inc. buyer in Q2 2026 was Jane Street, an estimated $90.2K added.
- The largest Endovia Health Sciences, Inc. seller in Q2 2026 was HRT Financial, an estimated $20.1K sold.
Based on aggregated 13F filings for Q2 2026.